Unihealth Hospitals Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 28, 2026

Key Highlights

The Latest Trading Price of Unihealth Hospitals Ltd is ₹ 564.95 as of 28 Oct 15:30 . The P/E Ratio of Unihealth Hospitals Ltd changed from 20.2 on March 2024 to 22 on March 2026 . This represents a CAGR of 2.89% over 3 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Unihealth Hospitals Ltd changed from ₹ 207.9 crore on March 2024 to ₹ 568.97 crore on March 2026 . This represents a CAGR of 39.88% over 3 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The Dividend Payout of Unihealth Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Unihealth Hospitals Ltd

Unihealth Consultancy Limited was incorporated as Private Limited Company under the name 'Unihealth Consultancy Private Limited', Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on February 26, 2010.
The Company status changed to Public Limited, and its name was changed to 'Unihealth Consultancy Limited' dated April 26, 2023 issued by the Registrar of Companies, Mumbai. Unihealth Consultancy Limited is the Holding Company of the Group providing healthcare consultancy and management services.
The Company facilitates medical value travel for patients travelling from various countries into Middle East and Africa to India for advanced medical care services.
The Company is a healthcare service provider based out of Mumbai, India having operational presence in multiple countries across the African continent.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Unihealth Hospitals Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Unihealth Hospitals Ltd or Vanta Bioscience Ltd?

Market cap of Unihealth Hospitals Ltd is 898 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Unihealth Hospitals Ltd and Vanta Bioscience Ltd?

The stock performance of Unihealth Hospitals Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Unihealth Hospitals Ltd and Vanta Bioscience Ltd?

As of October 28, 2026, the Unihealth Hospitals Ltd stock price is INR ₹564.95. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Unihealth Hospitals Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Unihealth Hospitals Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.